Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.64% vs 7.11% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 288.58% vs -120.45% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 1,611.46% vs 206.08% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is -2.83% vs -14.75% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Orchid Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 14.64% vs 7.11% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.05% vs 9.39% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 288.58% vs -120.45% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 6.68% vs -32.37% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 1,611.46% vs 206.08% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -3.97% vs -3.25% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -2.83% vs -14.75% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -21.17% vs 12.97% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025






